This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

DAVID ADLERSBERG, M.D.; HENRY COLCHER, M.D.; CHUN-I WANG, M.D.

AMA Arch Intern Med. 1953;92(5):615-627.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THIS STUDY is concerned with the effects of hydrocortisone (compound F) in patients with intractable primary sprue. Two forms of this steroid were used, the acetate and the free alcohol. While hydrocortisone acetate proved ineffective, the free alcohol of hydrocortisone, given orally, was found to be a valuable therapeutic agent in the management of these patients. The study represents an extension of our previous observations on the effects of corticotropin and cortisone acetate in sprue.¹

SELECTION OF PATIENTS

The diagnosis of primary sprue was based on the typical symptoms and signs of this disorder, namely, diarrhea and steatorrhea, weakness, considerable weight loss, soreness of mouth and tongue, anemia, and polyavitaminosis; the condition was associated in some instances with hypocalcemia, tetany, osteoporosis, and hypoproteinemia. In none of these patients was there evidence of pancreatic disease, and results of pancreatic enzyme studies, when performed, proved to be essentially normal. Roentgen studies . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the Nutrition Clinic and the Department of Medicine, Mount Sinai Hospital, New York.

Footnotes
Read before the joint meeting of the Section on Gastroenterology and Proctology and the Section on Pathology and Physiology at the 102nd Annual Session of the American Medical Association, New York, June 4, 1953.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?